Companies: 10,795·Total market cap: $144.5T
Guardant Health, Inc.

Guardant Health, Inc.

GHNASDAQHealthcare● Active
$127.07
+$1.46(+1.16%)
Market Cap$16.8B
P/E Ratio
52W High$133.97
52W Low$40.35

Guardant Health, Inc.(GH)内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。

SEC EDGAR · FMP · GH · 截至 2026年6月8日

活动摘要

买入笔数

0

P-Purchase only

卖出笔数

107

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空
↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Guardant Health, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。

数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

GH 季度内部人买卖趋势

GH 内幕交易卖出 · GH 内幕交易买入 · 季度活动

买入总量(含股权归属)卖出总量
1.2M608K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · GH CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

GH 高管卖出股份 · GH 董事内幕交易 · SEC Form 4申报

显示最近 69 条 · 普通股 · 仅Form 4

横向滑动查看全部列

Krognes Steve E.

Director

Sale

日期

Jun 4

股数

9,294

均价

$132.51

总金额

$1.23M ⚡

View Form 4 on SEC.gov

Joyce Meghan V.

Director

Option

日期

Jun 3

股数

8,803

均价

$38.01

总金额

$335K

View Form 4 on SEC.gov

Joyce Meghan V.

Director

Sale

日期

Jun 3

股数

3,516

均价

$126.52

总金额

$445K

View Form 4 on SEC.gov

Joyce Meghan V.

Director

Option

日期

Jun 3

股数

1,197

均价

$38.42

总金额

$46K

View Form 4 on SEC.gov

Joyce Meghan V.

Director

Sale

日期

Jun 3

股数

5,728

均价

$127.11

总金额

$728K

View Form 4 on SEC.gov

Joyce Meghan V.

Director

Sale

日期

Jun 3

股数

650

均价

$128.02

总金额

$83K

View Form 4 on SEC.gov

Joyce Meghan V.

Director

Sale

日期

Jun 3

股数

106

均价

$129.31

总金额

$14K

View Form 4 on SEC.gov

Krognes Steve E.

Director

Option

日期

May 31

股数

154

均价

总金额

View Form 4 on SEC.gov

Hidalgo Medina Manuel

Director

Sale

日期

May 28

股数

1,000

均价

$130.06

总金额

$130K

View Form 4 on SEC.gov

Saia John G.

Chief Legal Officer

Sale

日期

May 27

股数

9,994

均价

$125.08

总金额

$1.25M ⚡

View Form 4 on SEC.gov

Saia John G.

Chief Legal Officer

Sale

日期

May 27

股数

6

均价

$126.08

总金额

$756

View Form 4 on SEC.gov

Freeman Chris

Chief Commercial Officer

Option

日期

May 22

股数

24,406

均价

$32.86

总金额

$802K

View Form 4 on SEC.gov

Freeman Chris

Chief Commercial Officer

Sale

日期

May 22

股数

24,406

均价

$118.67

总金额

$2.90M ⚡

View Form 4 on SEC.gov

Saia John G.

Chief Legal Officer

Sale

日期

May 20

股数

5,632

均价

$105.34

总金额

$593K

View Form 4 on SEC.gov

Saia John G.

Chief Legal Officer

Sale

日期

May 20

股数

7,187

均价

$106.71

总金额

$767K

View Form 4 on SEC.gov

Saia John G.

Chief Legal Officer

Sale

日期

May 20

股数

7,181

均价

$107.23

总金额

$770K

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

200

均价

$100.95

总金额

$20K

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

900

均价

$102.57

总金额

$92K

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

1,366

均价

$103.82

总金额

$142K

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

11,919

均价

$105.01

总金额

$1.25M ⚡

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

1,200

均价

$105.88

总金额

$127K

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

21,171

均价

$106.99

总金额

$2.27M ⚡

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

33,069

均价

$108.11

总金额

$3.57M ⚡

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

9,852

均价

$108.97

总金额

$1.07M ⚡

View Form 4 on SEC.gov

Talasaz AmirAli

Co-Chief Executive Officer · Director

Sale

日期

May 20

股数

28,908

均价

$110.10

总金额

$3.18M ⚡

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 GH 内幕交易

GH 内幕交易

Guardant Health, Inc.(GH)内幕交易数据来源于公司内部人(包括Talasaz AmirAli (Co-Chief Executive Officer · Director), Saia John G. (Chief Legal Officer), Freeman Chris (Chief Commercial Officer))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。GH内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。

如需查看Guardant Health, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →

买卖信号逻辑
acquisitionOrDisposition字段:
A = 买入 · D = 卖出(处置)
RSU归属(M-Exempt)不计入情绪判断
Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件
10b5-1预设交易计划,允许内部人按计划自动卖出
Open Mkt公开市场直接买卖(不含股权奖励和期权行权)

常见问题

GH 内幕交易 · 5个问题

Guardant Health, Inc.(GH)的内部人包括高管和董事,如Talasaz AmirAli (Co-Chief Executive Officer · Director), Saia John G. (Chief Legal Officer), Freeman Chris (Chief Commercial Officer)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

GH 董事内幕交易GH 内部人名单Guardant Health, Inc. 高管内幕活动

数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026